3,4-dihydroxyphenylacetic acid has been researched along with fenfluramine in 18 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 6 (33.33) | 18.7374 |
| 1990's | 8 (44.44) | 18.2507 |
| 2000's | 3 (16.67) | 29.6817 |
| 2010's | 1 (5.56) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Clemens, JA; Fuller, RW; Perry, KW | 1 |
| Culp, S; DeSouza, EB; Lehmann, J; Zaczek, R | 1 |
| Bolaños-Jimenez, F; Fattaccini, CM; Gozlan, H; Hamon, M | 1 |
| Fattaccini, CM; Gozlan, H; Hamon, M | 1 |
| Barthélémy, C; Bruneau, N; Jouve, J; Lelord, G; Roux, S | 1 |
| Barthelemy, C; Bruneau, N; Jouve, J; Lelord, G; Martineau, J; Muh, JP | 1 |
| Bettini, E; Ceci, A; Samanin, R; Spinelli, R | 1 |
| Nowakowska, E; Samanin, R; Spampinato, U | 1 |
| Clemens, JA; Fuller, RW; Snoddy, HD | 1 |
| Curzon, G; Datla, KP; Oluyomi, AO | 1 |
| Bonhomme, N; De Deurwaerdère, P; Le Moal, M; Spampinato, U | 1 |
| Cook, EH; Freedman, DX; Heller, W; Leventhal, BL; Morford, M; Ravitz, AJ | 1 |
| Marona-Lewicka, D; Nichols, DE; Rhee, GS; Sprague, JE | 1 |
| McCann, UD; Ricaurte, GA; Yuan, J | 1 |
| Fisher, H; Halladay, AK; Hesse, K; Kirschner, E; Wagner, GC | 1 |
| Cremers, TI; de Boer, SF; Koolhaas, JM; Lieuwes, N; van der Vegt, BJ | 1 |
| Belzung, C; Bodard, S; Chalon, S; Galineau, L; Guilloteau, D; Kodas, E | 1 |
| Alves, SE; Correa, L; Gautreaux, C; Gordon, M; Hickey, GJ; Lorrain, DS; Lubbers, LS; Luine, V; Zafian, PT | 1 |
3 trial(s) available for 3,4-dihydroxyphenylacetic acid and fenfluramine
| Article | Year |
|---|---|
Auditory evoked potential modifications according to clinical and biochemical responsiveness to fenfluramine treatment in children with autistic behavior.
Topics: 3,4-Dihydroxyphenylacetic Acid; Autistic Disorder; Child; Child, Preschool; Dopamine; Evoked Potentials, Auditory; Female; Fenfluramine; Homovanillic Acid; Humans; Male; Phenylacetates; Randomized Controlled Trials as Topic; Reaction Time; Serotonin | 1989 |
Urinary dopamine metabolites as indicators of the responsiveness to fenfluramine treatment in children with autistic behavior.
Topics: 3,4-Dihydroxyphenylacetic Acid; Autistic Disorder; Child; Child, Preschool; Dopamine; Double-Blind Method; Female; Fenfluramine; Homovanillic Acid; Humans; Male; Serotonin | 1989 |
Clinical and neurochemical effects of fenfluramine in children with autism.
Topics: 3,4-Dihydroxyphenylacetic Acid; Adolescent; Autistic Disorder; Child; Child Behavior Disorders; Child, Preschool; Cognition; Double-Blind Method; Female; Fenfluramine; Humans; Intelligence; Male; Norepinephrine; Placebos; Plasma; Psychiatric Status Rating Scales; Serotonin; Surveys and Questionnaires | 1993 |
15 other study(ies) available for 3,4-dihydroxyphenylacetic acid and fenfluramine
| Article | Year |
|---|---|
Elevation of 3, 4-dihydroxyphenylacetic acid concentrations in rat brain and stimulation of prolactin secretion by fenfluramine: evidence for antagonism at dopamine receptor sites.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Brain; Brain Chemistry; Fenfluramine; Male; Norfenfluramine; p-Chloroamphetamine; Phenylacetates; Prolactin; Rats; Receptors, Dopamine; Stimulation, Chemical; Time Factors | 1976 |
Regional distribution to recovery of 5-HT levels after administration of "atrophins" MDMA and D,L-fenfluramine. Stereospecificity and comparison with 5,7-dihydroxytryptamine.
Topics: 3,4-Dihydroxyphenylacetic Acid; 3,4-Methylenedioxyamphetamine; 5,7-Dihydroxytryptamine; Animals; Atrophy; Brain; Cerebral Ventricles; Designer Drugs; Dopamine; Fenfluramine; Homovanillic Acid; Hydroxyindoleacetic Acid; Injections, Intraventricular; Male; N-Methyl-3,4-methylenedioxyamphetamine; Norepinephrine; Organ Specificity; Paroxetine; Piperidines; Rats; Rats, Inbred Strains; Serotonin; Stereoisomerism | 1992 |
Tianeptine stimulates uptake of 5-hydroxytryptamine in vivo in the rat brain.
Topics: 3,4-Dihydroxyphenylacetic Acid; Amphetamines; Animals; Antidepressive Agents, Tricyclic; Brain; Dopamine; Fenfluramine; Hydroxyindoleacetic Acid; Male; Rats; Rats, Inbred Strains; Serotonin; Synaptosomes; Thiazepines | 1990 |
Differential effects of d-fenfluramine and p-chloroamphetamine on H75/12-induced depletion of 5-hydroxytryptamine and dopamine in the rat brain.
Topics: 3,4-Dihydroxyphenylacetic Acid; Amphetamines; Animals; Brain; Brain Stem; Cerebral Cortex; Corpus Striatum; Dopamine; Fenfluramine; Hippocampus; Homovanillic Acid; Hydroxyindoleacetic Acid; Male; Monoamine Oxidase Inhibitors; p-Chloroamphetamine; Rats; Rats, Inbred Strains; Reference Values; Serotonin | 1991 |
Neuroleptic-like effects of the l-isomer of fenfluramine on striatal dopamine release in freely moving rats.
Topics: 3,4-Dihydroxyphenylacetic Acid; 4-Butyrolactone; Animals; Antipsychotic Agents; Corpus Striatum; Dopamine; Drug Tolerance; Fenfluramine; Haloperidol; Homovanillic Acid; Male; Rats; Receptors, Dopamine; Secretory Rate | 1987 |
Increased release of striatal dopamine after long-term treatment with methadone in rats: inhibition by agents which increase central 5-hydroxytryptamine transmission.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Corpus Striatum; Dopamine; Fenfluramine; Homovanillic Acid; Male; Methadone; Piperazines; Rats; Serotonin; Synaptic Transmission | 1983 |
Elevation by fenfluramine of 3,4-dihydroxyphenylacetic acid in brain and of corticosterone and prolactin in serum of fenfluramine-pretreated rats.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Brain Chemistry; Corticosterone; Fenfluramine; Male; Phenylacetates; Prolactin; Rats; Serotonin | 1981 |
Effects of d-fenfluramine on feeding and hypothalamic 5-hydroxytryptamine and dopamine in male and female rats.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Diet; Dopamine; Feeding Behavior; Female; Fenfluramine; Food Deprivation; Hydroxyindoleacetic Acid; Hypothalamus; Male; Rats; Rats, Sprague-Dawley; Serotonin; Sex Characteristics | 1994 |
d-fenfluramine increases striatal extracellular dopamine in vivo independently of serotonergic terminals or dopamine uptake sites.
Topics: 3,4-Dihydroxyphenylacetic Acid; 5,7-Dihydroxytryptamine; Anesthesia; Animals; Citalopram; Corpus Striatum; Dialysis; Dopamine; Dose-Response Relationship, Drug; Extracellular Space; Fenfluramine; Halothane; Hydroxyindoleacetic Acid; Male; Nomifensine; Rats; Rats, Sprague-Dawley; Serotonin; Tetrodotoxin | 1995 |
Reinforcing effects of certain serotonin-releasing amphetamine derivatives.
Topics: 3,4-Dihydroxyphenylacetic Acid; Amphetamines; Animals; Conditioning, Operant; Dopamine; Dopamine Antagonists; Fenfluramine; Indans; Male; Microdialysis; N-Methyl-3,4-methylenedioxyamphetamine; Nucleus Accumbens; Rats; Reinforcement, Psychology; Serotonin; Serotonin Agents; Serotonin Receptor Agonists; Synaptic Transmission | 1996 |
Neurotoxic effects of +/-fenfluramine and phenteramine, alone and in combination, on monoamine neurons in the mouse brain.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Appetite Depressants; Biogenic Monoamines; Body Weight; Brain; Dopamine; Drinking Behavior; Drug Interactions; Energy Intake; Feeding Behavior; Fenfluramine; Hydroxyindoleacetic Acid; Male; Mice; Neurons; Neurotoxins; Phentermine; Serotonin | 1998 |
Role of monoamine oxidase inhibition and monoamine depletion in fenfluramine-induced neurotoxicity and serotonin release.
Topics: 3,4-Dihydroxyphenylacetic Acid; alpha-Methyltyrosine; Animals; Clorgyline; Corpus Striatum; Dopamine; Drug Interactions; Fenclonine; Fenfluramine; Homovanillic Acid; Hydroxyindoleacetic Acid; Male; Monoamine Oxidase Inhibitors; Rats; Rats, Sprague-Dawley; Selective Serotonin Reuptake Inhibitors; Selegiline; Serotonin; Serotonin Antagonists; Tryptophan | 2001 |
Cerebrospinal fluid monoamine and metabolite concentrations and aggression in rats.
Topics: 3,4-Dihydroxyphenylacetic Acid; 5,7-Dihydroxytryptamine; Aggression; Animals; Biogenic Monoamines; Chromatography, High Pressure Liquid; Dopamine; Fenfluramine; Hydroxyindoleacetic Acid; Male; Norepinephrine; Piperazines; Pyridines; Rats; Selective Serotonin Reuptake Inhibitors; Serotonin; Serotonin Antagonists; Serotonin Receptor Agonists | 2003 |
Prenatal 3,4-methylenedioxymethamphetamine (ecstasy) exposure induces long-term alterations in the dopaminergic and serotonergic functions in the rat.
Topics: 3,4-Dihydroxyphenylacetic Acid; 3,4-Methylenedioxyamphetamine; Adrenergic Uptake Inhibitors; Age Factors; Analysis of Variance; Animals; Animals, Newborn; Autoradiography; Brain; Brain Chemistry; Dopamine; Embryo, Mammalian; Female; Fenfluramine; Hallucinogens; Homovanillic Acid; Hydroxyindoleacetic Acid; Male; Membrane Transport Proteins; Microdialysis; Nortropanes; Pregnancy; Prenatal Exposure Delayed Effects; Rats; Rats, Wistar; Selective Serotonin Reuptake Inhibitors; Serotonin; Sex Factors; Time Factors; Tyramine | 2005 |
Estrogen receptor (ER) subtype agonists alter monoamine levels in the female rat brain.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Biogenic Monoamines; Cerebral Cortex; Estradiol; Estrogen Receptor alpha; Estrogen Receptor beta; Female; Fenfluramine; Fluorenes; Hippocampus; Hydroxyindoleacetic Acid; Methoxyhydroxyphenylglycol; Norepinephrine; Ovariectomy; Phenols; Pyrazoles; Rats; Rats, Sprague-Dawley; Receptors, Estrogen | 2010 |